About Belmar Pharma Solutions
Belmar Pharma Solutions is a Healthcare company based in Golden (United States) founded in 2019, and was acquired by MedEquity in May 2019. Compounded medications, education, and consultation services are provided. Belmar Pharma Solutions has completed 1 acquisition, including Women's International Pharmacy. Its chief executive, as recorded, is Dave Hill. Its website belmarpharmasolutions.com draws about 22 thousand monthly visits. Belmar Pharma Solutions offers products and services including Hormone Pellets, Low Dose Naltrexone, Thyroid Hormones, and Testosterone Cypionate. Its focus areas include Services for Healthcare Providers and Continuing Medical Education. Its competitors include AngelEye Health, Pediatrix Medical Group and Weill Cornell Medicine; 1 of its 3 listed competitors has raised funding.
Company details
Belmar Pharma Solutions was established in 2019 in Golden, United States, focusing on the pharmaceutical sector. Compounded medications are prepared and distributed, alongside educational programs and consultation services for healthcare needs. Operations are centered on personalized pharmaceutical solutions, with the companys domain listed as belmarpharmasolutions.com. Leadership is provided by CEO Dave Hill, supporting service delivery in the region.
- Headquarters Golden, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website belmarpharmasolutions.com
- Social LinkedIn Facebook
- Acquired by MedEquity (May 2019)
- InvestorsWebster Equity Partners
& 1 more
- Investments & Acquisitions
- Acquired byMedEquity
(May 2019)
Products & Services of Belmar Pharma Solutions
Belmar Pharma Solutions offers a comprehensive portfolio of products and services, including Hormone Pellets, Low Dose Naltrexone, Thyroid Hormones, and Testosterone Cypionate.
Customized pellets for hormone replacement therapy.
Treatment for chronic conditions like autoimmune diseases.
Compounded options for thyroid health management.
Injectable for hormone balance in men's health.
Investors in Belmar Pharma Solutions
Belmar Pharma Solutions has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Webster Equity Partners and MedEquity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare-focused private equity investments are managed by the firm. | 2003 | websterequitypartners.com | Waltham, United States | |
Acquisitions are targeted by MedEquity as a private equity firm. | medequity.com | Wellesley, United States |
Investor details for Belmar Pharma Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Belmar Pharma Solutions
2 people are tracked at Belmar Pharma Solutions (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Dave Hill | CEO | Leadership |
Brandon Ingersoll | Chairman | Team |
Complete people profiles for Belmar Pharma Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Belmar Pharma Solutions
Belmar Pharma Solutions has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Women's International Pharmacy.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Compounded medications for women's health needs are provided internationally. | womensinternational.com | Madison, United States | 1985 | Jun 2021 | β’β’β’β’ |
Complete acquisition details for Belmar Pharma Solutions
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Belmar Pharma Solutions
3 dated milestones of Belmar Pharma Solutions across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Belmar Pharma Solutions is founded.
- Exit Acquired by MedEquity.
- Acquisition Acquires Women's International Pharmacy.
Competitors of Belmar Pharma Solutions
Belmar Pharma Solutions has 3 listed competitors in our database, 1 of them funded. They include AngelEye Health, Pediatrix Medical Group and Weill Cornell Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| angeleyehealth.com | 2013 | Nashville, United States | $16.34M | Provider of NICU cameras, communication, feed management, and education services for hospitals | ||
| pediatrix.com | 1979 | Sunrise, United States | Continuing medical education training and courses are provided to professionals. | |||
| weill.cornell.edu | 1898 | United States | Provider of medical education, research, and patient care. This organization offers MD and graduate degree programs, conducts cutting-edge biomedical research, and delivers exemplary patient care through affiliated hospitals. Faculty are engaged in clinical practice and scientific discovery, translating breakthroughs into improved treatments and prevention strategies. The institution fosters a culture of mentorship and supports global health initiatives. Educational programs are highly selective and include international partnerships. Research focuses on advancing knowledge in areas such as cancer and cardiovascular disease. |
Detailed competitors of Belmar Pharma Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Belmar Pharma Solutions
The website of Belmar Pharma Solutions (belmarpharmasolutions.com) receives about 21.6K visits a month.
- Monthly visits21.6K
▼ 4.4% vs previous month
Websites whose visitors overlap most with Belmar Pharma Solutions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| retinacolorado.com | 100% | 9.4K | #2,219,856 | View details | |
claymanpharmacy.com | claymanpharmacy.com | 99% | #1,561,519 | β | |
hydramed.com | hydramed.com | 91% | #514,931 | β | |
| hint.com | 82% | 351.5K | #110,438 | View details | |
empireplanproviders.com | empireplanproviders.com | 82% | #1,718,015 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 38 similar websites and full traffic analytics for Belmar Pharma Solutions
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 38 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as Belmar Pharma Solutions (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Belmar Pharma Solutions
Complete news archive for Belmar Pharma Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Belmar Pharma Solutions
Belmar Pharma Solutions was founded in 2019.
Belmar Pharma Solutions is headquartered in Golden, United States. It is registered at Golden, Colorado, United States.
Dave Hill is the CEO of Belmar Pharma Solutions, as recorded in our data.
Belmar Pharma Solutions was established in 2019 in Golden, United States, focusing on the pharmaceutical sector. Compounded medications are prepared and distributed, alongside educational programs and consultation services for healthcare needs. Operations are centered on personalized pharmaceutical solutions, with the companys domain listed as belmarpharmasolutions.com. Leadership is provided by CEO Dave Hill, supporting service delivery in the region.
Belmar Pharma Solutions's top competitors include Weill Cornell Medicine, AngelEye Health and Pediatrix Medical Group.
Belmar Pharma Solutions offers Hormone Pellets, Low Dose Naltrexone, Thyroid Hormones, and Testosterone Cypionate.
Belmar Pharma Solutions has made 1 acquisition, including Women's International Pharmacy.
Belmar Pharma Solutions has 2 investors. Key investors include Webster Equity Partners, and MedEquity.
Yes. Belmar Pharma Solutions was acquired by MedEquity in May 2019.

